PLX PEER ANALYSIS

Protalix Biotherapeutics Inc — metric-by-metric comparison with peers and the industry median

PLXProtalix Biotherapeutics Inc

🇺🇸 USA · AMEX · Healthcare · Biotechnology

Value it Duel

Overall Profile & Returns

· Biotechnology

Position Within Industry

0 = weak quartile, 100 = strong quartile

PLXIndustry median

Scores normalize each metric against industry quartiles (p25–p75); direction is inverted for lower-is-better metrics.

Return Comparison

1-Year

Split-adjusted

Year-to-Date (YTD)

Key Metric Comparison

P/E

Lower is better

ROE

Higher is better

Net Margin

Higher is better

Revenue Growth

Higher is better

All Metrics

Valuation
Metric	PLX	RTALB	MSB	TLX	Ind. Median
P/E	12.89	4.92●	—	—	18.00
P/B	2.94	0.61●	—	6.26	3.60
EV/EBITDA	6.91●	75.02	—	118.24	15.20
P/S	2.59●	6.71	30.99	3.18	10.43

Financial Health
Metric	PLX	RTALB	MSB	TLX	Ind. Median
Current Ratio	3.15●	1.21	—	1.43	5.90
Debt/Equity	12.6%	1.2%●	—	112.3%	10.9%
NetDebt/EBITDA	-1.94●	0.90	—	13.13	1.15

Profitability
Metric	PLX	RTALB	MSB	TLX	Ind. Median
Net Margin	20.1%	136.3%●	-115.3%	-0.9%	-125.7%
ROE	27.3%●	15.1%	-11.3%	-1.8%	-47.5%
ROA	17.4%●	13.1%	-8.6%	-0.7%	-35.8%
EBITDA Margin	29.2%●	9.0%	-76.6%	3.0%	-105.8%

Growth + Dividend
Metric	PLX	RTALB	MSB	TLX	Ind. Median
Rev. Growth	27.8%	24.0%	410.4%●	56.3%	5.1%
NI Growth	292.3%●	134.0%	—	—	12.1%
Div. Yield	—	0.0%●	0.0%●	—	0.2%
Payout	—	0.0%	0.0%	—	0.0%

Valuation
Metric	PLX	CHRS	OVID	ARCT	IPSC	CRBU	Ind. Median
P/E	12.89	—	—	—	—	—	18.00
P/B	2.94	2.86	1.02	1.08	0.79●	1.82	3.60
EV/EBITDA	6.91	—	—	—	—	—	15.20
P/S	2.59●	4.80	28.26	4.57	—	16.60	10.43

Financial Health
Metric	PLX	CHRS	OVID	ARCT	IPSC	CRBU	Ind. Median
Current Ratio	3.15	1.56	10.17	6.31	10.25●	6.22	5.90
Debt/Equity	12.6%	69.2%	0.7%●	12.5%	18.1%	26.4%	10.9%
NetDebt/EBITDA	-1.94●	0.70	6.42	2.78	0.97	0.81	1.15

Profitability
Metric	PLX	CHRS	OVID	ARCT	IPSC	CRBU	Ind. Median
Net Margin	20.1%●	-323.5%	-339.3%	-173.5%	—	-1,189.1%	-125.7%
ROE	27.3%●	—	-18.8%	-37.0%	-42.7%	-83.5%	-47.5%
ROA	17.4%●	-47.6%	-15.7%	-27.3%	-33.6%	-63.0%	-35.8%
EBITDA Margin	29.2%●	-341.0%	-337.0%	-148.9%	—	-999.5%	-105.8%

Growth + Dividend
Metric	PLX	CHRS	OVID	ARCT	IPSC	CRBU	Ind. Median
Rev. Growth	27.8%	-76.3%	1,199.6%●	-66.4%	-100.0%	13.0%	5.1%
NI Growth	292.3%	—	—	—	—	—	12.1%
Div. Yield	—	—	—	—	—	—	0.2%
Payout	—	—	—	—	—	—	0.0%

The green dot marks the best value in the group given the metric direction (higher/lower is better). All metrics use trailing-twelve-month (TTM) data.

Go deeper on PLX

Run a DCF valuation

Full DCF model with editable assumptions

Start a head-to-head duel

Compare two stocks metric by metric

Filter in the stock screener

Build your own universe with 400+ metrics

Data on this page refreshes once per day. Price data as of Jul 8, 26. This content is for informational purposes only and is not investment advice.